SAMRAT PHARMACHEM Financial Statement Analysis
|
||
|
The Revenues of SAMRAT PHARMACHEM have increased by 1.52% YoY .
The Earnings Per Share (EPS) of SAMRAT PHARMACHEM has increased by 228.86 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SAMRAT PHARMACHEM Last 5 Annual Financial Results
[BOM: 530125]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹286 Cr | ₹282 Cr | ₹311 Cr | ₹222 Cr | ₹179 Cr |
| Expenses | ₹276 Cr | ₹279 Cr | ₹287 Cr | ₹198 Cr | ₹170 Cr |
| Operating Profit (Excl OI) | ₹10 Cr | ₹2.45 Cr | ₹24 Cr | ₹24 Cr | ₹8.67 Cr |
| Other Income | ₹0.98 Cr | ₹1.40 Cr | ₹0.48 Cr | ₹0.63 Cr | ₹0.46 Cr |
| Interest | ₹0.67 Cr | ₹0.69 Cr | ₹1.23 Cr | ₹0.68 Cr | ₹1.28 Cr |
| Depreciation | ₹0.66 Cr | ₹0.65 Cr | ₹0.64 Cr | ₹0.60 Cr | ₹0.49 Cr |
| Profit Before Tax | ₹9.89 Cr | ₹2.52 Cr | ₹23 Cr | ₹24 Cr | ₹7.34 Cr |
| Profit After Tax | ₹7.11 Cr | ₹2.16 Cr | ₹17 Cr | ₹17 Cr | ₹5.33 Cr |
| Earnings Per Share (Rs) | ₹23.02 | ₹7.00 | ₹53.83 | ₹55.62 | ₹17.26 |
| PAT Margin (%) | 2.49 | 0.77 | 5.35 | 7.75 | 2.61 |
| ROE(%) | 10.40 | 3.38 | 30.25 | 44.95 | 19.77 |
| ROCE(%) | 13.61 | 4.13 | 34.91 | 52.33 | 23.90 |
| Total Debt/Equity(x) | 0.14 | 0.13 | 0.30 | 0.16 | 0.30 |
Key Financials |
||
| Market Cap | : | ₹ 79.2 Cr |
| Revenue (TTM) | : | ₹ 289.4 Cr |
| Net Profit(TTM) | : | ₹ 1.6 Cr |
| EPS (TTM) | : | ₹ 5.1 |
| P/E (TTM) | : | 50.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAMRAT PHARMACHEM | -5.1% | -13.9% | -42.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 6.7% | 2.8% |
| DIVIS LABORATORIES | 1.9% | -0.5% | 6.9% |
| CIPLA | 1.8% | -3.2% | 2.1% |
| TORRENT PHARMACEUTICALS | 0.1% | 3.4% | 15.8% |
| DR REDDYS LABORATORIES | 2.7% | 0.4% | 3.4% |
| MANKIND PHARMA | 1.4% | -7.9% | -13% |
| ZYDUS LIFESCIENCES | 1.7% | -5.9% | -1.6% |
| LUPIN | 4.1% | 6.4% | 1.8% |
SAMRAT PHARMACHEM Revenues
[BOM: 530125]
| Y-o-Y | 1.52 % |
| 5 Yr CAGR | 12.41 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹286 Cr | 1.52 | |
| Mar2024 | ₹282 Cr | -9.36 | |
| Mar2023 | ₹311 Cr | 40.09 | |
| Mar2022 | ₹222 Cr | 23.87 | |
| Mar2021 | ₹179 Cr | - | |
SAMRAT PHARMACHEM Operating Profit
[BOM: 530125]
| Y-o-Y | 317.75 % |
| 5 Yr CAGR | 4.25 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 317.75 | |
| Mar2024 | ₹2.45 Cr | -89.76 | |
| Mar2023 | ₹24 Cr | -1.28 | |
| Mar2022 | ₹24 Cr | 179.61 | |
| Mar2021 | ₹8.67 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 311.49 % |
| 5 Yr CAGR | -7.26 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 3.58% | 311.49 | |
| Mar2024 | 0.87% | -88.70 | |
| Mar2023 | 7.7% | -29.55 | |
| Mar2022 | 10.93% | 125.83 | |
| Mar2021 | 4.84% | - | |
SAMRAT PHARMACHEM Profit After Tax
[BOM: 530125]
| Y-o-Y | 228.80 % |
| 5 Yr CAGR | 7.46 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.11 Cr | 228.80 | |
| Mar2024 | ₹2.16 Cr | -86.99 | |
| Mar2023 | ₹17 Cr | -3.22 | |
| Mar2022 | ₹17 Cr | 222.24 | |
| Mar2021 | ₹5.33 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 223.38 % |
| 5 Yr CAGR | -1.17 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 2.49 % | 223.38 | |
| Mar2024 | 0.77 % | -85.61 | |
| Mar2023 | 5.35 % | -30.97 | |
| Mar2022 | 7.75 % | 196.93 | |
| Mar2021 | 2.61 % | - | |
SAMRAT PHARMACHEM Earnings Per Share (EPS)
[BOM: 530125]
| Y-o-Y | 228.86 % |
| 5 Yr CAGR | 7.46 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 | 228.86 | |
| Mar2024 | ₹7.00 | -87.00 | |
| Mar2023 | ₹54 | -3.22 | |
| Mar2022 | ₹56 | 222.25 | |
| Mar2021 | ₹17 | - | |
SAMRAT PHARMACHEM Return on Capital Employed (ROCE)
[BOM: 530125]
| Y-o-Y | 229.54 % |
| 5 Yr CAGR | -13.13 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 13.61% | 229.54 | |
| Mar2024 | 4.13% | -88.17 | |
| Mar2023 | 34.91% | -33.29 | |
| Mar2022 | 52.33% | 118.95 | |
| Mar2021 | 23.9% | - | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Current Share Price | : | ₹255.4 |
| Current MarketCap | : | ₹ 79.2 Cr |
| Updated EOD on | : | Nov 28,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -5.1% |
-13.9% |
-42.5% |
| SENSEX | 0.6% |
1.3% |
7% |
SAMRAT PHARMACHEM related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SAMRAT PHARMACHEM Financials
How the annual revenues of SAMRAT PHARMACHEM have changed ?
The Revenues of SAMRAT PHARMACHEM have increased by 1.52% YoY .
How the Earnings per Share (EPS) of SAMRAT PHARMACHEM have changed?
The Earnings Per Share (EPS) of SAMRAT PHARMACHEM has increased by 228.86 % YoY .
Check out Intrinsic Value of Peers of SAMRAT PHARMACHEM
Compare Stock Analytics of Peers of SAMRAT PHARMACHEM
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
